Tyrosinemia type 1 is a monogenic IEM secondary to Fah1 gene mutations which can be partially stabilized by upregulation of enzyme 4-hydroxyphenylpyruvate dioxygenase (HPD) activity. The gene discussed is FA2H; the disease is Tyrosinemia type 1.